Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC73138 structure
    GC73138PBENZ-DBRMD
    CAS: 1454662-41-9
    纯度: >99.00%

    PBENZ-DBRMD是一种强效的碘三碱脱碘酶3型(DIO3)抑制剂。

  • GC73144 structure
    GC73144K284-6111
    CAS: 702668-62-0
    纯度: >98.00%

    K284-6111是一种对蛋白质几丁质酶3样1(CHI3L1)具有口服活性的抑制剂。

  • GC73159 structure
    GC73159KTX-582
    CAS: 2573298-13-0
    纯度: >98.00%

    KTX-582是一种有效的IRAK4降解剂,IRAK4和Ikaros的DC50值分别为4nM和5nM。

  • GC73166 structure
    GC73166U7D-1
    纯度: >99.00%

    U7D-1是一流的有效和选择性USP7(泛素特异性蛋白酶7)PROTAC降解剂,在RS4;11细胞中的DC50为33 nM。

  • GC73180 structure
    GC73180Vidutolimod sodium
    纯度: >90.00%

    Vidutolimod sodium是一个CpG-A寡脱氧核苷酸。

  • GC73186 structure
    GC73186STING-IN-6
    CAS: 2305940-34-3
    纯度: >98.00%

    STING-IN-6(化合物50)是一种有效的STING抑制剂,pIC50为8.9。

  • GC73188 structure
    GC73188SFI003
    CAS: 2361332-90-1
    纯度: >99.00%

    SFI003是一种SRSF3抑制剂,通过SRSF3/DHCR24/ROS轴驱动CRC细胞凋亡,在体外和体内均表现出强大的抗肿瘤作用。

  • GC73198 structure
    GC73198PSMA I&T
    CAS: 2192281-54-0
    纯度: >99.00%

    PSMA I&T是前列腺特异性膜抗原(PSMA)的有效抑制剂。

  • GC73199 structure
    GC73199M47
    CAS: 890808-56-7
    纯度: >99.00%

    M47是一种小分子,选择性地破坏隐色素1 (CRY1)的稳定性,并增加细胞核中CRY1的降解。

  • GC73210 structure
    GC73210MTR-106
    CAS: 1639357-93-9
    纯度: >99.00%

    MTR-106是一种强效的口服活性G-四链体稳定剂和RNA聚合酶I抑制剂。

  • GC73212 structure
    GC73212TH-6
    CAS: 3031349-25-1
    纯度: >95.00%

    TH-6是一种强效的HDAC抑制剂,HDAC1、HDAC2、HDAC3、HDAC6、HDAC8的IC50分别为0.115、0.135、0.242、0.138、2.120µM。

  • GC73225 structure
    GC73225ROS-generating agent 1
    CAS: 2369030-41-9
    纯度: >99.00%

    ROS-generating agent 1(化合物2c)共价修饰TrxR的Sec-498残基生成ROS。

  • GC73232 structure
    GC73232PRDX1-IN-1
    纯度: >98.00%

    PRDX1-IN-1是PRDX1的选择性抑制剂,IC50值为0.164μM。

  • GC73234 structure
    GC73234MY-673
    CAS: 2944459-96-3
    纯度: >98.00%

    MY-673是抑制微管蛋白聚合的秋水仙素结合位点抑制剂(CBSI)。

  • GC73237 structure
    GC73237BWA-522
    CAS: 3042820-12-9
    纯度: >99.00%

    BWA-522是一种口服小分子蛋白靶向嵌合体(PROTACs),对AR-FL和AR-V7具有显著的降解作用。

  • GC73243 structure
    GC73243Nrf2-IN-3
    CAS: 6325-13-9
    纯度: >99.00%

    Nrf2-IN-3(化合物R16)是一种Nrf2抑制剂。

  • GC73268 structure
    GC73268PH14
    纯度: >99.00%

    PH14是PI3K/HDAC双抑制剂,对PI3Kα和HDAC3的IC50值分别为20.3 nM和24.5 nM。

  • GC73269 structure
    GC73269ABBV-467
    CAS: 2287186-66-5
    纯度: >99.00%

    ABBV-467是一种选择性MCL-1抑制剂(Ki: <0.01 nM)。

  • GC73272 structure
    GC73272PARP-1-IN-3
    CAS: 2976342-33-1
    纯度: >99.00%

    PARP-1-IN-3苯甲酰胺衍生物是一种强效的PARP-1抑制剂,PARP-1和PARP-2的IC50值分别为0.25 nM和2.34 nM。

  • GC73274 structure
    GC73274EGFR T790M/L858R-IN-2
    CAS: 2955607-40-4
    纯度: >99.00%

    EGFR T790M/L858R-IN-2是一种有效的选择性EGFRT790M/L858R抑制剂,对EGFRT790M/L858R和EGFR WT的IC50值分别为3.5和1290 nM。

  • GC73288 structure
    GC73288CDK8-IN-13
    CAS: 918523-75-8
    纯度: >98.00%

    CDK8-IN-13是一种强效、选择性且口服有效的CDK8抑制剂,IC 50 值为51.9nM。

  • GC73294 structure
    GC73294F5446
    CAS: 2304465-89-0
    纯度: >99.00%

    F5446(化合物1)是SUV39H1金属转移酶的选择性小分子抑制剂。

  • GC73301 structure
    GC733015-Aminosalicylic acid-d3
    CAS: 1309283-32-6
    纯度: >99.00%

    5-Aminosalicylic acid-d3是氘标记的5-氨基水杨酸。

  • GC73309 structure
    GC73309Anti-melanoma agent 1
    CAS: 2418579-17-4
    纯度: >99.00%

    Anti-melanoma agent 1(化合物5m)是一种抗黑色素瘤药物,可诱导细胞凋亡。